Global Pharmaceutical Company Honors Former CEO with Permanent Legacy at
Alma Mater
PHILADELPHIA, May 22 /PRNewswire-FirstCall/ -- GlaxoSmithKline (NYSE: GSK) today announced the establishment of two fellowships totaling $500,000 in honor of former Chief Executive Officer Jean-Pierre Garnier, to support students enrolled at Stanford Graduate School of Business. Dr. Garnier, who received his Masters of Business Administration from the school in 1974, retired from GSK on May 21, 2008.
Dr. Garnier served as the CEO of GSK since its creation in 2001, steering it through a complex merger and driving the development of one of the strongest new product pipelines in the industry. These funds will provide an ongoing tribute to his success as the leader of the world's second-largest research-based pharmaceutical company.
"Every successful company invests in the business to grow the bottom line," said Sir Christopher Gent, GSK Chairman. "We believe that business should also invest in something less tangible, less quantifiable, but of equal importance-building its reputation with the society it serves. GSK is pleased to honor Dr. Garnier's legacy by providing funds that will help develop the business leaders of tomorrow."
"This generous gift honors an alumnus whose leadership throughout his career has changed lives, changed organizations, and ultimately changed the world," said Robert L. Joss, Dean of the Stanford Graduate School of Business. "The fellowships being established in his honor ensure that Jean-Pierre Garnier will continue to have an impact on shaping the next generation of principled, innovative, and insightful business leaders."
Investing in the Best and Brightest
To remain competitive, Stanford Business School must attract and enroll
the best and the brightest students. The school's international reputation
as a leader in management education is built on the quality and diversity
of
'/>"/>
| SOURCE GlaxoSmithKline Copyright©2008 PR Newswire. All rights reserved |